Subcutaneous administration of the monoclonal antibody L9LS protected adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal antibody administered ...

This program was developed to prepare pharmacists to administer medications and immunizations by injection. The legislation surrounding this expanded scope of practice is in various stages in each ...

September 23, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of the risks for encephalopathy and aseptic meningitis in patients receiving metronidazole ...